337 related articles for article (PubMed ID: 16433450)
41. Gene therapy for inherited immunodeficiencies.
Howe S; Thrasher AJ
Curr Hematol Rep; 2003 Jul; 2(4):328-34. PubMed ID: 12901330
[TBL] [Abstract][Full Text] [Related]
42. Micro-injection-mediated hematopoietic stem cell gene therapy.
Davis BR; Brown DB; Prokopishyn NL; Yannariello-Brown J
Curr Opin Mol Ther; 2000 Aug; 2(4):412-9. PubMed ID: 11249771
[TBL] [Abstract][Full Text] [Related]
43. Fragile sites are preferential targets for integrations of MLV vectors in gene therapy.
Bester AC; Schwartz M; Schmidt M; Garrigue A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Ben-Porat N; Von Kalle C; Fischer A; Kerem B
Gene Ther; 2006 Jul; 13(13):1057-9. PubMed ID: 16511518
[TBL] [Abstract][Full Text] [Related]
44. A review of gene therapy for haematological disorders.
Nathwani AC; Davidoff AM; Linch DC
Br J Haematol; 2005 Jan; 128(1):3-17. PubMed ID: 15606545
[TBL] [Abstract][Full Text] [Related]
45. Gene therapy for immune disorders: good news tempered by bad news.
Puck JM; Malech HL
J Allergy Clin Immunol; 2006 Apr; 117(4):865-9. PubMed ID: 16630946
[TBL] [Abstract][Full Text] [Related]
46. Severe combined immunodeficiency (SCID): from molecular basis to clinical management.
Sponzilli I; Notarangelo LD
Acta Biomed; 2011 Apr; 82(1):5-13. PubMed ID: 22069950
[TBL] [Abstract][Full Text] [Related]
47. [Hematopoietic malignancies and gene therapy].
Ozawa K
Gan To Kagaku Ryoho; 2003 Apr; 30(4):478-82. PubMed ID: 12722677
[TBL] [Abstract][Full Text] [Related]
48. French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.
European Society of Gene Therapy
J Gene Med; 2003 Jan; 5(1):82-4. PubMed ID: 12516054
[No Abstract] [Full Text] [Related]
49. Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug.
Ferrua F; Aiuti A
Hum Gene Ther; 2017 Nov; 28(11):972-981. PubMed ID: 28847159
[TBL] [Abstract][Full Text] [Related]
50. Clinical research. Gene therapy a suspect in leukemia-like disease.
Marshall E
Science; 2002 Oct; 298(5591):34-5. PubMed ID: 12364755
[No Abstract] [Full Text] [Related]
51. Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry.
Sanchez JJ; Monaghan G; Børsting C; Norbury G; Morling N; Gaspar HB
Ann Hum Genet; 2007 May; 71(Pt 3):336-47. PubMed ID: 17181544
[TBL] [Abstract][Full Text] [Related]
52. Gene therapy for childhood immunological diseases.
Kohn DB
Bone Marrow Transplant; 2008 Jan; 41(2):199-205. PubMed ID: 17994122
[TBL] [Abstract][Full Text] [Related]
53. Hematopoietic stem cell transplantation for primary immunodeficiency disease.
Dvorak CC; Cowan MJ
Bone Marrow Transplant; 2008 Jan; 41(2):119-26. PubMed ID: 17968328
[TBL] [Abstract][Full Text] [Related]
54. Gene therapy of severe combined immunodeficiencies.
Fischer A; Hacein-Bey S; Cavazzana-Calvo M
Nat Rev Immunol; 2002 Aug; 2(8):615-21. PubMed ID: 12154380
[TBL] [Abstract][Full Text] [Related]
55. Gene therapy: X-SCID transgene leukaemogenicity.
Thrasher AJ; Gaspar HB; Baum C; Modlich U; Schambach A; Candotti F; Otsu M; Sorrentino B; Scobie L; Cameron E; Blyth K; Neil J; Abina SH; Cavazzana-Calvo M; Fischer A
Nature; 2006 Sep; 443(7109):E5-6; discussion E6-7. PubMed ID: 16988659
[TBL] [Abstract][Full Text] [Related]
56. Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT).
Gansbacher B;
J Gene Med; 2003 Mar; 5(3):261-2. PubMed ID: 12666192
[No Abstract] [Full Text] [Related]
57. Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells.
Siapati EK; Bigger BW; Kashofer K; Themis M; Thrasher AJ; Bonnet D
Eur J Haematol; 2007 Apr; 78(4):303-13. PubMed ID: 17378892
[TBL] [Abstract][Full Text] [Related]
58. Severe combined immunodeficiency: a national surveillance study.
Yee A; De Ravin SS; Elliott E; Ziegler JB;
Pediatr Allergy Immunol; 2008 Jun; 19(4):298-302. PubMed ID: 18221464
[TBL] [Abstract][Full Text] [Related]
59. [Recent developments in gene therapy].
Vandendriessche T
Verh K Acad Geneeskd Belg; 2004; 66(4):305-17; discussion 317-20. PubMed ID: 15553101
[TBL] [Abstract][Full Text] [Related]
60. Visible integration of the adenosine deaminase (ADA) gene into the recipient genome after gene therapy.
Egashira M; Ariga T; Kawamura N; Miyoshi O; Niikawa N; Sakiyama Y
Am J Med Genet; 1998 Jan; 75(3):314-7. PubMed ID: 9475605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
